Free Trial

Avantor, Inc. (NYSE:AVTR) Shares Bought by Asset Management One Co. Ltd.

Avantor logo with Medical background

Asset Management One Co. Ltd. raised its position in Avantor, Inc. (NYSE:AVTR - Free Report) by 10.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 260,109 shares of the company's stock after acquiring an additional 23,639 shares during the period. Asset Management One Co. Ltd.'s holdings in Avantor were worth $4,216,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Avantor by 10.5% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 6,257 shares of the company's stock worth $132,000 after purchasing an additional 592 shares during the last quarter. American Trust raised its position in Avantor by 4.5% during the 4th quarter. American Trust now owns 15,198 shares of the company's stock worth $320,000 after buying an additional 658 shares during the last quarter. Smartleaf Asset Management LLC lifted its stake in Avantor by 106.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company's stock valued at $34,000 after acquiring an additional 830 shares during the period. Nissay Asset Management Corp Japan ADV boosted its holdings in shares of Avantor by 1.0% in the 4th quarter. Nissay Asset Management Corp Japan ADV now owns 82,523 shares of the company's stock valued at $1,767,000 after acquiring an additional 857 shares during the last quarter. Finally, Portside Wealth Group LLC boosted its holdings in shares of Avantor by 9.0% in the 1st quarter. Portside Wealth Group LLC now owns 10,673 shares of the company's stock valued at $173,000 after acquiring an additional 882 shares during the last quarter. 95.08% of the stock is currently owned by institutional investors and hedge funds.

Avantor Price Performance

AVTR stock traded down $0.01 during trading on Thursday, hitting $13.88. The stock had a trading volume of 6,225,578 shares, compared to its average volume of 8,394,696. The company's 50-day moving average price is $13.14 and its two-hundred day moving average price is $16.72. Avantor, Inc. has a twelve month low of $11.82 and a twelve month high of $28.00. The stock has a market capitalization of $9.46 billion, a P/E ratio of 13.35, a PEG ratio of 1.48 and a beta of 1.05. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.12 and a quick ratio of 0.75.

Avantor (NYSE:AVTR - Get Free Report) last posted its quarterly earnings results on Friday, April 25th. The company reported $0.23 earnings per share for the quarter, hitting the consensus estimate of $0.23. The firm had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.61 billion. Avantor had a net margin of 10.70% and a return on equity of 11.93%. The company's revenue for the quarter was down 5.9% on a year-over-year basis. During the same period last year, the firm posted $0.22 earnings per share. As a group, research analysts predict that Avantor, Inc. will post 1.06 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on AVTR. Barclays decreased their target price on shares of Avantor from $18.00 to $15.00 and set an "overweight" rating for the company in a research report on Monday, April 28th. Cowen cut Avantor from a "buy" rating to a "hold" rating in a report on Monday, April 28th. TD Cowen lowered Avantor from a "buy" rating to a "hold" rating and set a $15.50 target price on the stock. in a report on Monday, April 28th. The Goldman Sachs Group cut Avantor from a "buy" rating to a "neutral" rating and reduced their price target for the company from $23.00 to $14.00 in a research report on Tuesday, April 29th. Finally, Morgan Stanley lowered Avantor from an "overweight" rating to an "equal weight" rating in a research report on Tuesday, April 29th. Seven equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to data from MarketBeat.com, Avantor has a consensus rating of "Hold" and an average price target of $18.14.

View Our Latest Stock Report on Avantor

Insider Buying and Selling

In related news, Director Gregory L. Summe purchased 30,000 shares of Avantor stock in a transaction dated Friday, May 23rd. The shares were acquired at an average price of $12.50 per share, for a total transaction of $375,000.00. Following the acquisition, the director directly owned 100,000 shares in the company, valued at approximately $1,250,000. The trade was a 42.86% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Joseph R. Massaro acquired 8,100 shares of the company's stock in a transaction that occurred on Tuesday, April 29th. The stock was purchased at an average cost of $12.30 per share, with a total value of $99,630.00. Following the acquisition, the director directly owned 35,038 shares of the company's stock, valued at $430,967.40. This trade represents a 30.07% increase in their position. The disclosure for this purchase can be found here. Insiders bought 83,100 shares of company stock valued at $1,027,630 over the last 90 days. Company insiders own 1.20% of the company's stock.

About Avantor

(Free Report)

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Read More

Institutional Ownership by Quarter for Avantor (NYSE:AVTR)

Should You Invest $1,000 in Avantor Right Now?

Before you consider Avantor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.

While Avantor currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Drone Stocks Are Skyrocketing Right Now!
Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters
This Strategy Beat the S&P—And Most Investors Ignore It

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines